The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world (RW) use of niraparib (Nir) monotherapy (mono) as first-line (1L) switch maintenance (1LSM) therapy following chemotherapy (CT) plus bevacizumab (bev) induction treatment in patients (pts) with epithelial ovarian cancer (EOC) in the SW1TCH study.
 
BJ Rimel
Honoraria - Genentech
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Deep 6 AI; Genentech/Roche; GlaxoSmithKline; Merck; Tesaro
 
Tirza Areli Calderón Boyle
Employment - GlaxoSmithKline
 
Jessica Perhanidis
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - Boston Scientific; GlaxoSmithKline
 
Sara Burns
Employment - GlaxoSmithKline
 
Jonathan Lim
Employment - GlaxoSmithKline
 
John Hartman
Employment - GlaxoSmithKline
 
Linda Kalilani
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Jeanne M. Schilder
Employment - GlaxoSmithKline
 
Jean A. Hurteau
Employment - GlaxoSmithKline
 
Amanda Golembesky
Employment - GlaxoSmithKline